Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
D000328:Adult; D000353:Africa, Southern; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003692:Delayed-Action Preparations; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005277:Fenfluramine / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity
D003692:Delayed-Action Preparations; D005277:Fenfluramine